Immunogenicity and Safety of a Multi-Dose Quadrivalent Influenza Vaccine

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
The aim of the study is to to assess the immunogenicity and safety of a quadrivalent influenza vaccine in a multi-dose presentation compared to a quadrivalent influenza vaccine in single-dose presentation, in children aged 6 months to 17 years.
Epistemonikos ID: fc7611af4b2cb46942ad1b7eff71397e504990e2
First added on: May 21, 2024